Narwhal Capital Management Sells 6,687 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Narwhal Capital Management lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 15.6% in the 4th quarter, Holdings Channel reports. The firm owned 36,161 shares of the healthcare conglomerate’s stock after selling 6,687 shares during the quarter. UnitedHealth Group accounts for approximately 1.6% of Narwhal Capital Management’s portfolio, making the stock its 13th biggest position. Narwhal Capital Management’s holdings in UnitedHealth Group were worth $18,293,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of UNH. Dark Forest Capital Management LP lifted its position in shares of UnitedHealth Group by 76.9% during the second quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock worth $374,000 after purchasing an additional 319 shares during the last quarter. Forefront Analytics LLC lifted its holdings in UnitedHealth Group by 6.4% during the 2nd quarter. Forefront Analytics LLC now owns 877 shares of the healthcare conglomerate’s stock valued at $449,000 after buying an additional 53 shares in the last quarter. Buck Wealth Strategies LLC bought a new position in UnitedHealth Group in the 2nd quarter worth about $7,112,000. Copperwynd Financial LLC raised its stake in shares of UnitedHealth Group by 24.2% during the second quarter. Copperwynd Financial LLC now owns 1,775 shares of the healthcare conglomerate’s stock valued at $904,000 after acquiring an additional 346 shares in the last quarter. Finally, Magnolia Capital Advisors LLC grew its stake in UnitedHealth Group by 322.7% in the second quarter. Magnolia Capital Advisors LLC now owns 13,661 shares of the healthcare conglomerate’s stock worth $6,957,000 after purchasing an additional 10,429 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on UNH shares. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $627.74.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Up 0.5 %

UnitedHealth Group stock opened at $532.26 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market cap of $489.83 billion, a PE ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The business’s 50-day simple moving average is $541.04 and its two-hundred day simple moving average is $564.34.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the business posted $5.83 EPS. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.58%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.